Učitavanje...
Use of thiazolidinediones and the risk of bladder cancer among people with type 2 diabetes: a meta-analysis
BACKGROUND: Patients with type 2 diabetes have a 40% increased risk of bladder cancer. Thiazolidinediones, especially pioglitazone, may increase the risk. We conducted a systematic review and meta-analysis to evaluate the risk of bladder cancer among adults with type 2 diabetes taking thiazolidinedi...
Spremljeno u:
| Glavni autori: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Canadian Medical Association
2012
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3447078/ https://ncbi.nlm.nih.gov/pubmed/22761478 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1503/cmaj.112102 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|